Aggressive Lymphomas

MD IQ

Conference Coverage

Relapsed MCL: Options for treatment

There are a number of treatment options for relapsed MCL, but BTK inhibitors are particularly useful.

FDA/CDC

FDA puts selinexor on fast track for DLBCL

Selinexor has received fast track designation to treat patients with previously treated DLBCL who are not eligible for certain therapies.

Conference Coverage

When to choose stem cell transplant in PTCL

DUBROVNIK, CROATIA – Dr. Ali Bazarbachi gives his tips for when to use allo- versus auto-HSCT in patients with peripheral T-cell lymphomas.

Pages